APA

Heidenreich P. A., Davis B. R., Cutler J. A., Furberg C. D., Lairson D. R., Shlipak M. G., Pressel S. L., Nwachuku C. & Goldman L. (20080513). Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). : Journal of general internal medicine.

Chicago

Heidenreich Paul A, Davis Barry R, Cutler Jeffrey A, Furberg Curt D, Lairson David R, Shlipak Michael G, Pressel Sara L, Nwachuku Chuke and Goldman Lee. 20080513. Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). : Journal of general internal medicine.

Harvard

Heidenreich P. A., Davis B. R., Cutler J. A., Furberg C. D., Lairson D. R., Shlipak M. G., Pressel S. L., Nwachuku C. and Goldman L. (20080513). Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). : Journal of general internal medicine.

MLA

Heidenreich Paul A, Davis Barry R, Cutler Jeffrey A, Furberg Curt D, Lairson David R, Shlipak Michael G, Pressel Sara L, Nwachuku Chuke and Goldman Lee. Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). : Journal of general internal medicine. 20080513.